4Braunschweig R, Yah P, Guilleret I, et al. Detection of malignant effusions : comparison of a telomerase assay and cytologic examination. Diagn Cytopathol,2001,24 : 174-180.
5Motherby H, Nadjari B, Friegel P, et al. Diagnostic accuracy of effusion cytology. Diagn Cytopathol, 1999,20 : 350 -357.
6Idell S, Girard W, Koenig KB, et al. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis, 1991,144 : 187-194.
7Pappot H, Gardsvoll H, Rφmer J, et al. Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe Seyler, 1995,376:259-267.
8Aleman C, Alegre J, Monasterio J, et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) ,2003,105:601-607.
9Hua CC, Chang LC, Chen YC, et al. Prointlammatory eytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest, 1999,116 : 1292-1296.
10Chung CL, Chen YC, Chang SC, et al. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest ,2003,123 : 1188-1195.
